erlotinib hydrochloride has been researched along with nsc 74859 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (nsc 74859) | Trials (nsc 74859) | Recent Studies (post-2010) (nsc 74859) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 101 | 0 | 91 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | nsc 74859 (IC50) |
|---|---|---|---|
| Vif | Human immunodeficiency virus 1 | 64.06 | |
| Tat | Human immunodeficiency virus 1 | 75.277 | |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 4.636 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 64.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Liang, G; Luo, W; Qian, Y; Wang, J; Wang, Y; Xu, Z; Yin, H; Zheng, C; Zhuang, F | 1 |
1 other study(ies) available for erlotinib hydrochloride and nsc 74859
| Article | Year |
|---|---|
Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes.
Topics: Aminosalicylic Acids; Animals; Benzenesulfonates; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Rats; STAT3 Transcription Factor | 2019 |